Scarica l'app Stockscreener
3.03
5.67%
0.1625
Pre-mercato:
3.10
0.07
+2.31%
Precedente Chiudi:
$2.8675
Aprire:
$3.055
Volume 24 ore:
224.71K
Relative Volume:
3.47
Capitalizzazione di mercato:
$10.86M
Reddito:
$815.40K
Utile/perdita netta:
$-14.03M
Rapporto P/E:
-0.0574
EPS:
-52.8093
Flusso di cassa netto:
$-9.68M
1 W Prestazione:
+16.85%
1M Prestazione:
-8.11%
6M Prestazione:
-81.00%
1 anno Prestazione:
-92.78%
Intervallo 1D:
$2.56
$3.6138
Intervallo di 1 settimana:
$2.257
$3.6138
Portata 52W:
$2.1975
$74.29
Onconetix Inc Stock (ONCO) Company Profile
Nome
Onconetix Inc
Settore
Industria
Telefono
513-620-4101
Indirizzo
201 E. FIFTH STREET, CINCINNATI
Compare ONCO vs VRTX, REGN, ALNY, ARGX, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
3.03 | 10.86M | 815.40K | -14.03M | -9.68M | -52.81 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Onconetix Inc Borsa (ONCO) Ultime notizie
Onconetix announces 1-for-5 reverse stock split - MSN
Onconetix (ONCO) formalizes new CEO deal and reshapes its board - Stock Titan
Cincinnati public firm names CEO, its fifth in two years, amid acquisition news - The Business Journals
Realbotix Humanoid Robot Showcased in Ericsson's 6G Trial as Onconetix Moves to Acquire Realbotix Corp. - Quiver Quantitative
A humanoid robot joined Ericsson’s live 6G test as Onconetix eyes deal - Stock Titan
Onconetix, Inc. Appoints David White as Chief Executive Officer – March 2026 SEC 8-K Filing - Minichart
Onconetix, Inc. Announces 1-for-5 Reverse Stock Split - Sahm
Onconetix Appoints New CEO and Refreshes Board Leadership - TipRanks
Onconetix On March 18 Appointed David White As CEO, Effective As Of That Date - TradingView
Onconetix names David White as CEO; Sammy Dorf joins board as Timothy Ramdeen resigns - TradingView
New CEO and board reshuffle at Onconetix (NASDAQ: ONCO) - Stock Titan
Onconetix approves 1-for-5 reverse stock split effective March 25 - Investing.com Australia
Onconetix approves 1-for-5 reverse stock split effective March 25 By Investing.com - Investing.com South Africa
Onconetix, Inc. announces 1-for-5 reverse stock split - marketscreener.com
If You Invested $1,000 in Onconetix (ONCO) - Stock Titan
Onconetix, Inc. (ONCO) Competitors - Meyka
Onconetix (ONCO) asks shareholders to OK 1-for-2 to 1-for-10 reverse split - Stock Titan
Growth Review: Is Onconetix Inc stock a good dividend stock2026 Breakouts & Daily Price Action Insights - baoquankhu1.vn
ONCO Stock Price, Quote & Chart | ONCONETIX INC (NASDAQ:ONCO) - ChartMill
Onconetix (Formerly Blue Water Vaccines) Pursues Proclarix Commercialization and Realbotix Acquisition for Growth in Men’s Health and Oncology Diagnostics 25293041 - Minichart
Onconetix 2025 10-K: Revenue $0.82M, EPS $(16.56) - TradingView
ONCO: Net loss narrowed in 2025, but liquidity and going concern risks persist amid ongoing reliance on Proclarix - TradingView
Onconetix (NASDAQ: ONCO) 10-K flags going concern risk and major Realbotix reverse merger - Stock Titan
Onconetix, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Aug PreEarnings: Is Onconetix Inc forming a double bottom2026 EndofYear Setup & Daily Profit Focused Screening - baoquankhu1.vn
Short Interest in Onconetix Drops by 76.1% - National Today
Buyout Rumor: How does Onconetix Inc perform in inflationary periodsMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Trend Report: Why is Onconetix Inc stock going downJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Swing Trade: What is the long term forecast for Onconetix Inc stockJuly 2025 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
ONCO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sentiment Recap: Can Onconetix Inc reach all time highs this yearExit Point & Safe Entry Zone Identification - baoquankhu1.vn
Chipmakers Recap: How does AVNS perform in inflationary periodsJuly 2025 Closing Moves & Fast Moving Stock Watchlists - baoquankhu1.vn
Onconetix, Inc. (NASDAQ:ONCO) Short Interest Down 13.9% in January - Defense World
Why is Onconetix Inc. stock going down2025 Major Catalysts & High Accuracy Swing Entry Alerts - mfd.ru
Aug Rallies: What is the long term forecast for Onconetix Inc. stockJuly 2025 Institutional & High Accuracy Trade Signal Alerts - mfd.ru
How big funds are accumulating Onconetix Inc. (J4T) stock2025 Technical Overview & Fast Exit and Entry Strategy Plans - mfd.ru
Trend Review: Does Onconetix Inc have a sustainable dividend2025 Key Highlights & Free Community Consensus Stock Picks - baoquankhu1.vn
Is Onconetix Inc Gaining or Losing Market Support? - Benzinga
Onconetix to Acquire Humanoid Robot Subsidiary of Realbotix - AI Insider
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Cincinnati public firm pivots to AI robots - WKRC
Realbotix Corp. announces the sale of Realbotix, LLC subsidiary to a Nasdaq listed issuer - marketscreener.com
United States shares lower at close of trade; Dow Jones Industrial Average down 1.34% By Investing.com - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.34% - Investing.com
Onconetix to acquire Realbotix LLC, USA-based, AI-powered humanoid Robotics company - marketscreener.com
Realbotix, LLC entered into a Share Exchange Agreement to acquire Onconetix, Inc. in a reverse merger transaction. - marketscreener.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer - 01net
Realbotix Announces the Sale of Realbotix, LLC Subsidiary to Onconetix - marketscreener.com
Onconetix Stock Plunges On Realbotix Acquisition - Nasdaq
ONCO Stock Dips Amid Staggering Financial Challenges - StocksToTrade
Onconetix Inc Azioni (ONCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):